Stock ELEV ELEVATION ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Elevation Oncology, Inc.

Equities

ELEV

US28623U1016

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-31 EDT 		5-day change 1st Jan Change
4.02 USD -1.23% Intraday chart for Elevation Oncology, Inc. +4.69% +648.60%
05-31 Piper Sandler Starts Elevation Oncology With Overweight Rating, $10 Price Target MT
05-14 Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ELEVATION ONCOLOGY, INC. Stock Elevation Oncology, Inc.
 222M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
BIONTECH SE Stock BioNTech SE
 23.83B -
ARGENX SE Stock argenx SE
 21.73B -
GENMAB A/S Stock Genmab A/S
 18.1B
  1. Stock Market
  2. Equities
  3. ELEV Stock
  4. Charts Elevation Oncology, Inc.
  5. Sector Chart